FDMT: 4D Molecular Therapeutics Inc
今日FDMT汇率已更改-13.69%。当日,交易品种以低点8.55和高点10.02进行交易。
关注4D Molecular Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
FDMT新闻
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at Bank of America Global Healthcare Conference 2026 Transcript
- 4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates
- Aclaris Therapeutics (ACRS) Reports Q1 Loss, Beats Revenue Estimates
- electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?
- 4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings and Revenues Beat Estimates
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:FDMT) 2026-01-19
- RBC Capital 维持4D Molecular股票"跑赢大盘"评级,目标价32美元
- RBC Capital reiterates Outperform rating on 4D Molecular stock at $32
- 4D分子治疗公司财务副总裁Ashoo Gupta出售价值3.3千美元FDMT股票
- Ashoo Gupta of 4D Molecular Therapeutics sells $3.3k in FDMT stock
- 4D Molecular Therapeutics: Jury Still Out On CF Gene Therapy After Dense Data Drop (NASDAQ:FDMT)
- BlackBerry, FedEx, Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Aimei Health Technology (NASDAQ:AFJK), Aura Biosciences (NASDAQ:AURA)
- Avago and Oracle among market cap stock movers on Wednesday
- 4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential Transcript
- 4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential - Slideshow (NASDAQ:FDMT) 2025-12-17
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies London Healthcare Conference 2025 Transcript
- 4D分子治疗公司首席法律官出售价值1.7万美元的股票
- 4d Molecular Therapeutics chief legal officer sells $17k in stock
- 4D分子治疗公司任命Kristian Humer为首席财务官
- 4D Molecular Therapeutics appoints Kristian Humer as chief financial officer
- RBC将4D分子治疗公司目标价格上调至32美元,基于资金状况
- 4D Molecular Therapeutics stock price target raised by RBC to $32 on funding
常见问题解答
FDMT股票今天的价格是多少?
4D Molecular Therapeutics Inc股票今天的定价为8.64。它在8.55 - 10.02范围内交易,昨天的收盘价为10.01,交易量达到1425。FDMT的实时价格图表显示了这些更新。
4D Molecular Therapeutics Inc股票是否支付股息?
4D Molecular Therapeutics Inc目前的价值为8.64。股息政策取决于公司,而投资者也会关注-23.54%和USD。实时查看图表以跟踪FDMT走势。
如何购买FDMT股票?
您可以以8.64的当前价格购买4D Molecular Therapeutics Inc股票。订单通常设置在8.64或8.94附近,而1425和-12.99%显示市场活动。立即关注FDMT的实时图表更新。
如何投资FDMT股票?
投资4D Molecular Therapeutics Inc需要考虑年度范围6.96 - 12.34和当前价格8.64。许多人在以8.64或8.94下订单之前,会比较-11.75%和。实时查看FDMT价格图表,了解每日变化。
4D Molecular Therapeutics Inc股票的最高价格是多少?
在过去一年中,4D Molecular Therapeutics Inc的最高价格是12.34。在6.96 - 12.34内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪4D Molecular Therapeutics Inc的绩效。
4D Molecular Therapeutics Inc股票的最低价格是多少?
4D Molecular Therapeutics Inc(FDMT)的最低价格为6.96。将其与当前的8.64和6.96 - 12.34进行比较,可以发现潜在的长期切入点。观看FDMT在图表上的实时走势以获取更多详细信息。
FDMT股票是什么时候拆分的?
4D Molecular Therapeutics Inc历史上曾经历过股票拆分。这些变化在公司行动后的、10.01和-23.54%中可见。
- 前一天收盘价
- 10.01
- 开盘价
- 9.93
- 卖价
- 8.64
- 买价
- 8.94
- 最低价
- 8.55
- 最高价
- 10.02
- 交易量
- 1.425 K
- 日变化
- -13.69%
- 月变化
- -11.75%
- 6个月变化
- 13.24%
- 年变化
- -23.54%
- 实际值
- 预测值
- 前值